Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 10.3389/fphar.2019.01615 Pharmacology Correction Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition Trommer Maike 1 2 3 * † Yeo Sin Yuin 2 4 † Persigehl Thorsten 3 4 Bunck Anne 3 4 Grüll Holger 2 4 Schlaak Max 2 5 Theurich Sebastian 2 6 7 von Bergwelt-Baildon Michael 2 6 Morgenthaler Janis 1 3 Herter Jan M. 1 3 8 Celik Eren 1 3 Marnitz Simone 1 2 3 Baues Christian 1 2 3 1 Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany 2 Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany 3 Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany 4 Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany 5 Department of Dermatology and Allergology, Ludwig-Maximilians University Munich, Munich, Germany 6 Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany 7 Gene Center, Cancer- and Immunometabolism Research Group, Ludwig-Maximilians University Munich, Munich, Germany 8 Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Maike Trommer, maike.trommer@uk-koeln.de

†These authors have contributed equally to this work

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

 31 01 2020 2019 10 1615 28 11 2019 10 12 2019 Copyright © 2020 Trommer, Yeo, Persigehl, Bunck, Grüll, Schlaak, Theurich, von Bergwelt-Baildon, Morgenthaler, Herter, Celik, Marnitz and Baues 2020 Trommer, Yeo, Persigehl, Bunck, Grüll, Schlaak, Theurich, von Bergwelt-Baildon, Morgenthaler, Herter, Celik, Marnitz and Baues

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition by Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, and Baues C. (2019). Front. Pharmacol. 10:511. doi: 10.3389/fphar.2019.00511 abscopal effect PD-1 radio-immunotherapy radiotherapy combination treatment advanced cancer disease immune checkpoint inhibition

An author name was incorrectly spelled as “Michael von Bergwelt.” The correct spelling is “Michael von Bergwelt-Baildon”. The updated Author Contributions statement appears below.

“MT, SYY, and CB developed the conception and design of the study. MT, SYY, TP, AB, and HG discussed the cases in interdisciplinary panels. MT acquired patient data. MT and SYY organized the database, performed all analyses, and wrote the first draft of the manuscript. SYY, TP, and AB acquired the imaging data. TP, HG, MS, ST, MB-B, JM, JH, EC, SM, and CB contributed to the manuscript. All authors contributed to the revision and read and approved the submitted version.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.